Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPL
1926
DELISTED
EPL OIL & GAS, INC COMMON STK
EPL
| $1.38M | ﹤0.01% |
48,500
-126,300
| -72% | -$4.04M |
|
|
AHD
1927
DELISTED
ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE)
AHD
| $1.38M | ﹤0.01% |
29,412
-138,900
| -83% | -$6.51M |
|
|
ISS
1928
DELISTED
ISOFTSTONE HLDGS LTD ADS EACH REPSTG 10 ORD SHS (CYM)
ISS
| $1.38M | ﹤0.01% |
268,600
+18,098
| +7% | +$91.2K |
|
|
GRP.U
1929
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $1.37M | ﹤0.01% |
37,700
+15,900
| +73% | +$549K |
|
|
ASRT
1930
DELISTED
Assertio
ASRT
| $1.37M | ﹤0.01% |
+2,156
| New | +$1.05M |
|
|
ENH
1931
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $1.37M | ﹤0.01% |
23,300
+10,100
| +77% | +$563K |
|
|
CORV
1932
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $1.36M | ﹤0.01% |
218,913
+8,800
| +4% | +$46.1K |
|
1933
Orrstown Financial Services
ORRF
$841M
| $1.36M | ﹤0.01% |
83,300
+336
| +0.4% | +$5.58K |
|
|
FGH
1934
DELISTED
FG Group Holdings Inc.
FGH
| $1.36M | ﹤0.01% |
294,100
+24,200
| +9% | +$113K |
|
|
PEI
1935
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $1.36M | ﹤0.01% |
4,780
+1,253
| +36% | +$343K |
|
1936
Steris
STE
$22.5B
| $1.35M | ﹤0.01% |
28,200
-320,300
| -92% | -$14.6M |
|
|
INPH
1937
DELISTED
INTERPHASE CORP
INPH
| $1.35M | ﹤0.01% |
349,900
-2,700
| -0.8% | -$11.7K |
|
|
IPHI
1938
DELISTED
INPHI CORPORATION
IPHI
| $1.35M | ﹤0.01% |
104,400
+11,500
| +12% | +$147K |
|
|
XRTX
1939
DELISTED
XYRATEX LTD (BERMUDA)
XRTX
| $1.34M | ﹤0.01% |
101,233
+12,500
| +14% | +$134K |
|
1940
Euroseas
ESEA
$560M
| $1.34M | ﹤0.01% |
14,207
+424
| +3% | +$35.4K |
|
|
PMC
1941
DELISTED
PharMerica Corporation
PMC
| $1.33M | ﹤0.01% |
62,000
+15,700
| +34% | +$285K |
|
|
NNA
1942
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $1.33M | ﹤0.01% |
20,160
+4,831
| +32% | +$286K |
|
|
EMES
1943
DELISTED
Emerge Energy Services LP
EMES
| $1.33M | ﹤0.01% |
+30,032
| New | +$1.13M |
|
1944
Asure Software
ASUR
$240M
| $1.32M | ﹤0.01% |
236,076
-12,500
| -5% | -$63.7K |
|
|
SA
1945
Seabridge Gold
SA
$2.89B
| $1.32M | ﹤0.01% |
+180,999
| New | +$1.52M |
|
|
TLP
1946
DELISTED
Transmontaigne
TLP
| $1.32M | ﹤0.01% |
31,087
-17,213
| -36% | -$718K |
|
1947
Compugen
CGEN
$220M
| $1.32M | ﹤0.01% |
147,400
-50,278
| -25% | -$492K |
|
|
VXRT
1948
DELISTED
Vaxart
VXRT
| $1.32M | ﹤0.01% |
28,619
-322
| -1% | -$14.2K |
|
1949
Mueller Industries
MLI
$14.8B
| $1.32M | ﹤0.01% |
167,200
-403,200
| -71% | -$2.99M |
|
1950
BK Technologies
BKTI
$299M
| $1.31M | ﹤0.01% |
77,600
+4,220
| +6% | +$62.2K |
|
Similar funds
Renaissance Technologies's Q4 2013 Portfolio in Review
As of Q4 2013, Renaissance Technologies held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Pfizer worth $230M.
- Renaissance Technologies's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Renaissance Technologies added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Renaissance Technologies's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Renaissance Technologies fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Renaissance Technologies's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Renaissance Technologies opened 498 new positions and closed 464 in Q4 2013.
- Renaissance Technologies's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.